From Asset to Operation: Key Success Factors in ADC GMP Manufacturing Ramp-Up

• Samsung Biologics’ strategic expansion of its bioconjugation offerings 
• Building the right capabilities while navigating competing priorities
• Key learnings and success factors from ADC manufacturing ramp-up

Speakers:

Marc Studer

Senior Director & Head, ADC/mRNA Operations Team

Samsung Biologics